Abstract
Background A substantial proportion of individuals infected with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) report persisting symptoms weeks and months following acute infection. Estimates on prevalence vary due to differences in study designs, populations, heterogeneity of symptoms and the way symptoms are measured. Common symptoms include fatigue, cognitive impairment and dyspnea. However, knowledge regarding the nature and risk factors for developing persisting symptoms is still limited. Hence in this study we aim to determine the prevalence, severity, risk factors and impact on quality of life of persisting symptoms in the first year following acute SARS-CoV-2 infection.
Methods The LongCOVID-study is both a prospective and retrospective cohort study with a one year follow up. Participants aged 5 years and above with self-reported positive or negative tests for SARS-CoV-2 will be included in the study. The primary outcome is the prevalence and severity of persistent symptoms in participants that tested positive for SARS-CoV-2 compared to controls. Symptom severity will be assessed for fatigue using the Checklist Individual Strength (CIS subscale fatigue severity), pain (Rand-36/SF-36 subscale bodily pain), dyspnea (Medical Research Council (mMRC)) and cognitive impairment using the Cognitive Failure Questionnaire (CFQ). Secondary outcomes include loss of health-related quality of life (HRQoL) and risk factors for persisting symptoms following infection with SARS-CoV-2.
Discussion A better understanding regarding the nature of persisting symptoms following SARS-CoV-2 infection will enable better diagnosis, management and will consequently minimize negative consequences on quality of life.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The study is funded by Dutch Ministry of Health, Welfare and Sport. The funders do not have a role in the design of this study, its execution, analyses, interpretation of results, approval of the manuscript and decision to submit the manuscript for publication.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Utrecht Medical Ethics Committee (METC) declared in February 2021 that the Medical Research Involving Human Subjects Act (WMO) does not apply to this study (METC protocol number 21-124/C).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
This article is a protocol for an observational cohort study, hence data sharing is not applicable as no datasets were generated or analyzed during the current study.
List of abbreviations
- SARS-CoV-2
- Severe Acute Respiratory Syndrome Coronavirus-2
- CIS
- Checklist Individual Strength
- mMRC
- Medical Research Council
- HRQoL
- Health-Related Quality of Life
- RIVM
- Dutch National Institute for Public Health and the Environment
- METC
- Medical Ethics Review Committee
- WMO
- Medical Research Involving Human Subjects Act
- PCR
- Polymerase Chain Reaction
- BRP
- Basic Registration of Persons
- GGD
- Municipal Health Services
- CFQ
- Cognitive Failure Questionnaire
- Brief IPQ
- The Brief Illness Perception Questionnaire
- HADS
- Hospital Anxiety and Depression Scale
- NCSI
- Nijmegen Clinical Screening Instrument
- iPCQ
- iMTA Productivity Cost Questionnaire
- PedsQL
- Pediatric Quality of Life Inventory
- PedsQL fatigue
- Pediatric Quality of Life Inventory Fatigue Scale
- VAS
- Visual Analogue Scale
- PROMIS
- Patient-Reported Outcomes Measurement Information System
- QALYs
- Quality Adjusted Life Years
- SDQ
- Strengths and Difficulties Questionnaire
